- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 260.73M sh |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $887M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $798M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $928M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $836M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $2.87B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $2.7B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $4.29B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $4.12B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $1.28B |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $1.51B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 302.13M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $715M |
| Capex | Q1 2025 · Mar 31, 2024 | $14M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $105M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $3.14B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $3.75B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.43 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.47 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $98M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $115M |
| Net Income | Q1 2025 · Mar 31, 2024 | $130M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $144M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $614M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $206M |
| Revenue | Q1 2025 · Mar 31, 2024 | $820M |